PIQLF Dividend: Proteomics International Laboratories Ltd Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

PIQLF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	3	3	3	3	1	1
Revenue Growth (YoY)	0%	0%	0%	200%	0%	0%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	9	9	8	8	7	4
Research & Development	--	--	--	--	--	--
Operating Expenses	11	11	10	9	6	4
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-8	-8	-6	-6	-4	-2
Income Tax Expense	0	0	0	0	0	0
Net Income	-8	-8	-6	-6	-4	-2
Net Income Growth	33%	33%	0%	50%	100%	100%
Shares Outstanding (Diluted)	118.98	134.26	125.84	116.45	105.53	101.7
Shares Change (YoY)	-6%	7%	8%	10%	4%	16%
EPS (Diluted)	-0.06	-0.06	-0.05	-0.05	-0.04	-0.02
EPS Growth	19%	19%	-4%	13%	68%	41%
Free Cash Flow	-6	-6	-5	-6	-3	-2
Free Cash Flow Per Share	-0.05	-0.04	-0.03	-0.05	-0.02	-0.01
Gross Margin	--	--	--	--	--	--
Operating Margin	-266.66%	-266.66%	-200%	-200%	-400%	-300%
Profit Margin	-266.66%	-266.66%	-200%	-200%	-400%	-200%
Free Cash Flow Margin	-200%	-200%	-166.66%	-200%	-300%	-200%
EBITDA	-8	-8	-6	-6	-4	-3
EBITDA Margin	-266.66%	-266.66%	-200%	-200%	-400%	-300%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-8	-8	-6	-6	-4	-3
EBIT Margin	-266.66%	-266.66%	-200%	-200%	-400%	-300%
Effective Tax Rate	0%	0%	0%	0%	0%	0%